🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the immunogenicity of na...
Status
Terminated
Location
Research Site
Start Date
2014-12-01
Trial ID
NCT02142192
Treatments Being Tested
The purpose of this study is to evaluate the impact of an early treatment w...
Status
Completed
Location
Research Site
Start Date
2013-11-12
Trial ID
NCT04832399
Treatments Being Tested
Validating a peptide-based laboratory test enabling the measurement of Tysa...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2016-10
Trial ID
NCT02965170
The purpose of this study is to explore host genetic mutations which may re...
Status
Terminated
Location
North Central Neurology Associates
Start Date
2010-10
Trial ID
NCT01211639
The purpose of the study is to research the association between receiving T...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2012-07
Trial ID
NCT01626248
The primary objective of this study is to assess the efficacy of Ocrelizuma...
Status
Completed
Location
RWJBarnabas Health
Start Date
2017-06-01
Trial ID
NCT03157830
This research study is a Phase II clinical trial, which tests the safety an...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2015-01
Trial ID
NCT02176031
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of nataliz...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT02142205
Treatments Being Tested
The primary objective is to assess the pharmacokinetic (PK) profile of nata...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00744679
Treatments Being Tested
The primary objectives of the study are to estimate the risk of major conge...
Status
Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2023-10-27
Trial ID
NCT05658497
Treatments Being Tested